First Time Loading...

Neuroone Medical Technologies Corp
NASDAQ:NMTC

Watchlist Manager
Neuroone Medical Technologies Corp Logo
Neuroone Medical Technologies Corp
NASDAQ:NMTC
Watchlist
Price: 1.13 USD 1.8% Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

NMTC Price Targets Summary
Neuroone Medical Technologies Corp

Wall Street analysts forecast NMTC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NMTC is 3.15 USD .

NMTC Lowest Forecast
Wall Street Target
Not Available
NMTC Average Forecast
Wall Street Target
3.15 USD
179% Upside
NMTC Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
3.15 USD
179% Upside
Highest
Price Target
Not Available
Neuroone Medical Technologies Corp Competitors:
Price Targets
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
72% Upside
I
ITGR
Integer Holdings Corp
16% Upside
PDEX
Pro-Dex Inc
47% Upside
688626
Xiangyu Medical Co Ltd
51% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
72% Upside
I
ITGR
Integer Holdings Corp
16% Upside
PDEX
Pro-Dex Inc
47% Upside
688626
Xiangyu Medical Co Ltd
51% Upside
6823
Rion Co Ltd
36% Upside
RMD
Resmed Inc
5% Downside
CODX
Co-Diagnostics Inc
130% Upside
SIBN
SI-BONE Inc
84% Upside

Revenue
Forecast

Revenue Estimate
Neuroone Medical Technologies Corp

The compound annual growth rate of Neuroone Medical Technologies Corp's revenue for the next 2 years is 98%.

N/A
Past Growth
98%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Neuroone Medical Technologies Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Neuroone Medical Technologies Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
What are analyst estimates?

See Also

Summary
NMTC intrinsic value, competitors valuation, and company profile.
DCF Valuation
NMTC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NMTC stock valuation using valuation multiples.
Wall Street Estimates
NMTC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NMTC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NMTC's stock price target?
Price Target
3.15 USD

According to Wall Street analysts, the average 1-year price target for NMTC is 3.15 USD .

What is Neuroone Medical Technologies Corp's Revenue forecast?
Projected CAGR
98%

The compound annual growth rate of Neuroone Medical Technologies Corp's revenue for the next 2 years is 98%.

ALPHA SPREAD
Join more than 132,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.